Retour à la liste des actualités
3 novembre 2020

Rapid Vaccine Distribution to Over 7.5 Billion Humans

When a COVID-19 vaccine is developed and ready for distribution it will, in all likelihood, require cold chain services.

But, what environmental and economic costs will be attached to this logistical endeavour?

Who would have said a year ago that disruptions to supply chains, and more broadly, our way of life, would not come from a new company, a start-up, or a new economic model, but rather from a virus? The disruption caused by COVID-19 has been extensive, we cannot control its spread, and we do not understand its behaviour. How it affects our health varies from person to person for unknown reasons, and may include mild symptoms, severe symptoms, or even asymptotic cases in individuals who spread the virus unknowingly.

Let’s read the entire article.

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer November 2020, pages 10-11. © Samedan Ltd

Autres actualités

7 juin 2021

EMBALL’ISO, maillon fort de la chaine logistique du transport de médicaments

Les Echos, 4 juin 2021
Lire la suite
10 mai 2021

The logistics of a pandemic

As the pharmaceutical industry leapt up to meet the challenge of developing a vaccine to combat a global pandemic, its partners in the supply chain had to keep in step. Yann Martin, global sales director of isothermal solutions supplier EMBALL’ISO, tells us how the company ramped up its operations to cope with the surge in demand.
Lire la suite
23 février 2021

COVID-19 Vaccine Logistics Handbook

Discover how industry experts address the challenge of COVID-19 vaccine distribution and especially how EMBALL’ISO Reuse and Reverse Network can help make this distribution greener.
Lire la suite
26 janvier 2021

Welcome to our new Business Development Manager

In 2021, we will continue to grow and develop to support you where you are.
Lire la suite